Drug intelligence / Profile preview

DUSP4 siRNA

Development stage
Preclinical
Lead developer
The Chinese University of Hong Kong
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous
01

Overview

DUSP4 siRNA is a small interfering RNA designed to silence the expression of Dual Specificity Phosphatase 4 (DUSP4). DUSP4 is a member of the dual-specificity protein phosphatase subfamily that typically inactivates mitogen-activated protein kinases (MAPKs). In the context of multiple myeloma (MM), DUSP4 has been identified as a super-enhancer associated gene (SEAG) that is significantly overexpressed and correlates with inferior patient outcomes. By targeting DUSP4 mRNA for degradation through the RNA interference pathway, this siRNA inhibits the growth of myeloma cells, suggesting that DUSP4 acts as an oncogene in this malignancy. This agent is primarily utilized in preclinical research to validate DUSP4 as a viable therapeutic target in hematologic cancers.

Other names
siRNA targeting DUSP4DUSP4-targeting siRNADUSP-4-targeting siRNADUSP 4-targeting siRNADual specificity phosphatase 4 siRNA
02

Targets

DUSP4

Beyond the preview

Go deeper on DUSP4 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DUSP4 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call